PharmiWeb

During J. P. Morgan Healthcare Week, Biotech Showcaseโ„ข Provides Private and Micro- to Mid-Cap Public Company Executives One-Stop Access to Investors, Pharโ€ฆ

Join Bristol Myers Squibb, Genentech, Google, J.P. Morgan, Novo Nordisk, Pappas Capital, Amazon Web Services, BIO, Members of ...
BioSpace

At JPM26, Policy and Politics Will Loom Large for Pharma as Biotech Sees the Sun

Pharmas will need to provide their latest stance on the Most Favored Nation drug pricing plans, while biotech finally gets a ...

Immorta Bio Doubles Mouse Lifespan Using Combination Senolytic and Regenerative Therapy in Validated Aging Models

Immorta Bio Inc., a scientific longevity company dedicated to Treating Diseases of Aging and Treating Aging as Disease(TM), today announced new data demonstrating that its combination therapy of ...

K-Bio Heads to "JPM Week"... New Opportunities for Technology Transfer and Orders Open Up

The world's largest bio investment event, the JP Morgan Healthcare Conference (JPMHC), is just a week away. With the total ...
BioSpace

Revolution Soars Amid Swirling Buyout Rumors With Merck, AbbVie

Rumors of a Revolution buyout come as the industry gears up for one of its biggest trade conferences, where observers expect ...
Benzinga.com

JP Morgan Downgrades Gene Therapy Focused Bluebird Bio, Cites Limited Funding Options

On Thursday, Bluebird Bio Inc. (NASDAQ:BLUE) reported a third-quarter EPS loss of 31 cents, compared to a loss of 80 cents a year ago, beating the consensus loss of 36 cents. The gene therapy ...